Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma (2019)
Source: European Journal of Pharmacology. Unidade: FMRP
Subjects: ASMA, CANABINOIDES, FIBROSE PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VUOLO, Francieli et al. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. European Journal of Pharmacology, v. 843, p. 251-259, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2018.11.029. Acesso em: 02 nov. 2024.APA
Vuolo, F., Abreu, S. C., Michels, M., Xisto, D. G., Blanco, N. G., Hallak, J. E. C., et al. (2019). Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. European Journal of Pharmacology, 843, 251-259. doi:10.1016/j.ejphar.2018.11.029NLM
Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JEC, Zuardi AW, Crippa JA de S, Reis CM dos, Bahl M, Pizzichinni E, Maurici R, Pizzichini MMM, Rocco PRM, Dal-Pizzol F. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma [Internet]. European Journal of Pharmacology. 2019 ; 843 251-259.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2018.11.029Vancouver
Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JEC, Zuardi AW, Crippa JA de S, Reis CM dos, Bahl M, Pizzichinni E, Maurici R, Pizzichini MMM, Rocco PRM, Dal-Pizzol F. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma [Internet]. European Journal of Pharmacology. 2019 ; 843 251-259.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.ejphar.2018.11.029
